{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:55:10Z","timestamp":1791237310683,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004697","name":"Hamedan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbrep.2026.102713","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:28:53Z","timestamp":1784068133000},"page":"102713","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluation of oxidative stress and coagulation factors in MS patients throughout both relapse and remission stages"],"prefix":"10.1016","volume":"47","author":[{"given":"Nima","family":"Naseri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Harirchian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraj","family":"Khodadadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Ghiasian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Askari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3405-562X","authenticated-orcid":false,"given":"Ebrahim","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2026.102713_bib1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s13205-025-04548-3","article-title":"Multiple sclerosis: a comprehensive review of pathophysiology and combined natural-synthetic therapeutic strategies","volume":"15","author":"Al Amin","year":"2025","journal-title":"3 Biotech"},{"key":"10.1016\/j.bbrep.2026.102713_bib2","series-title":"Medical Sciences Forum","first-page":"41","article-title":"Evaluation of the coagulation dysfunction in multiple sclerosis from the perspective of IgG antibodies against thrombus-related components","author":"Hadjiagapiou","year":"2023"},{"key":"10.1016\/j.bbrep.2026.102713_bib3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.clineuro.2008.11.016","article-title":"Normal plasma antithrombin activity in patients with relapsing\u2013remitting and secondary progressive multiple sclerosis","volume":"111","author":"Campos-de-Magalh\u00e3es","year":"2009","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.bbrep.2026.102713_bib4","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3390\/biomedicines11030906","article-title":"A preclinical investigation on the role of IgG antibodies against coagulant components in multiple sclerosis","volume":"11","author":"Hadjiagapiou","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbrep.2026.102713_bib5","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/S0140-6736(17)30492-0","article-title":"Systemic inflammation and blood\u2013brain barrier abnormality in relapsing\u2013remitting multiple sclerosis","volume":"389","author":"Varatharaj","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bbrep.2026.102713_bib6","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/jth.12523","article-title":"The risk of venous thromboembolism in patients with multiple sclerosis: the clinical practice research datalink","volume":"12","author":"Peeters","year":"2014","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.bbrep.2026.102713_bib7","article-title":"Erythrocytes in multiple sclerosis\u2013forgotten contributors to the pathophysiology?","volume":"2","author":"Groen","year":"2016","journal-title":"Multiple Sclerosis J. Experimental, Trans. Clinical"},{"key":"10.1016\/j.bbrep.2026.102713_bib8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3389\/fneur.2019.00409","article-title":"Coagulation pathways in neurological diseases: multiple sclerosis","volume":"10","author":"Ziliotto","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbrep.2026.102713_bib9","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1177\/13524585211039111","article-title":"Hemostatic factors in the pathogenesis of neuroinflammation in multiple sclerosis","volume":"28","author":"Abbadessa","year":"2022","journal-title":"Multiple Sclerosis J."},{"key":"10.1016\/j.bbrep.2026.102713_bib10","first-page":"67","article-title":"D-dimer increasing after first alemtuzumab administration in a multiple sclerosis patient","author":"De Mercanti","year":"2019","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.bbrep.2026.102713_bib11","first-page":"245","article-title":"Serum NOXs and iron metabolism biomarkers in RRMS patients","volume":"41","author":"Kassem","year":"2024","journal-title":"Benha Med J"},{"key":"10.1016\/j.bbrep.2026.102713_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jns.2013.11.006","article-title":"Erythrocytes' antioxidative capacity as a potential marker of oxidative stress intensity in neuroinflammation","volume":"337","author":"Ljubisavljevic","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbrep.2026.102713_bib13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbrep.2026.102713_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/1874104502014010035","article-title":"Alleviates sperm Damagd by Limiting Oxidative Stress and Insulin Resistance in rDiabetic Rats","volume":"14","author":"Abbasi-Oshaghi","year":"2020","journal-title":"Open Med. Chem. J."},{"key":"10.1016\/j.bbrep.2026.102713_bib15","series-title":"Evaluation of Total Oxidant Status and Total Antioxidant Capacity in the Serum of Type 2 Diabetes Mellitus Male Patients","author":"Abdullah","year":"2024"},{"key":"10.1016\/j.bbrep.2026.102713_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/cdn\/nzaa078","article-title":"Targeted nutrient modifications in purified diets differentially affect nonalcoholic Fatty liver disease and metabolic disease development in rodent models","volume":"4","author":"Radhakrishnan","year":"2020","journal-title":"Curr. Dev. Nutr."},{"key":"10.1016\/j.bbrep.2026.102713_bib17","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.2217\/nnm-2018-0202","article-title":"Effects of ZnO nanoparticles on intestinal function and structure in normal\/high fat diet-fed rats and Caco-2 cells","volume":"13","author":"Abbasi-Oshaghi","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bbrep.2026.102713_bib18","first-page":"245","article-title":"The protective effects of virgin coconut oil on high-fat diet induced rat liver","volume":"22","author":"Arsang","year":"2020","journal-title":"J. Babol Univer. Med Sci."},{"key":"10.1016\/j.bbrep.2026.102713_bib19","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann. Neurol.: Official Journal of the American Neurological Association and the Child Neurology Society"},{"key":"10.1016\/j.bbrep.2026.102713_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.msard.2017.09.033","article-title":"Elevated plasma fibrinogen levels in multiple sclerosis patients during relapse","volume":"18","author":"Acu\u00f1a","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.bbrep.2026.102713_bib21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ana.24997","article-title":"Fibrin (ogen) and neurodegeneration in the progressive multiple sclerosis cortex","volume":"82","author":"Yates","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrep.2026.102713_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102509","article-title":"Fibrinogen: a potential biomarker for predicting disease severity in multiple sclerosis","volume":"46","author":"Ahmad","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.bbrep.2026.102713_bib23","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.3390\/diagnostics14222521","article-title":"Innovative diagnostic solutions in hemostasis","volume":"14","author":"Favaloro","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.bbrep.2026.102713_bib24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jocn.2007.02.090","article-title":"Coagulation status and biochemical and inflammatory markers in multiple sclerosis","volume":"15","author":"Aksungar","year":"2008","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.bbrep.2026.102713_bib25","article-title":"Analysis of CSF D-dimer to identify intrathecal fibrin-driven autoimmunity in patients with multiple sclerosis","volume":"9","author":"Schaller-Paule","year":"2022","journal-title":"Neurology: Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.bbrep.2026.102713_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/1352458520904277","article-title":"Elevated D-dimer as an immediate response to alemtuzumab treatment","volume":"27","author":"Libertinova","year":"2021","journal-title":"Multiple Sclerosis Journal"},{"key":"10.1016\/j.bbrep.2026.102713_bib27","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1093\/eurheartj\/ehx003","article-title":"Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European society of cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function","volume":"39","author":"Mazzolai","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbrep.2026.102713_bib28","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1007\/s00415-018-8994-5","article-title":"Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course","volume":"265","author":"Stampanoni Bassi","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbrep.2026.102713_bib29","article-title":"Analysis of IL-6, IL-1\u03b2 and TNF-\u03b1 production in monocytes isolated from multiple sclerosis patients treated with disease modifying drugs","volume":"3","author":"Fiedler","year":"2017","journal-title":"J. Sys. Integrative Neuroscience"},{"key":"10.1016\/j.bbrep.2026.102713_bib30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/icb.2014.15","article-title":"Expansion and preferential activation of the CD14+ CD16+ monocyte subset during multiple sclerosis","volume":"92","author":"Chuluundorj","year":"2014","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.bbrep.2026.102713_bib31","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jns.2016.12.039","article-title":"Disease progression and oxidative stress are associated with higher serum ferritin levels in patients with multiple sclerosis","volume":"373","author":"Ferreira","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbrep.2026.102713_bib32","doi-asserted-by":"crossref","first-page":"806","DOI":"10.4103\/neurol-india.NI_579_20","article-title":"Neutrophil-to-Lymphocyte Ratio, ESR, and CRP have no roles as markers for disease severity and prognosis in patients with RRMS","volume":"72","author":"Nikseresht","year":"2024","journal-title":"Neurol. India"},{"key":"10.1016\/j.bbrep.2026.102713_bib33","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.numecd.2005.05.003","article-title":"A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress","volume":"15","author":"Del Rio","year":"2005","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"key":"10.1016\/j.bbrep.2026.102713_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.expneurol.2015.11.010","article-title":"Oxidative stress in multiple sclerosis: central and peripheral mode of action","volume":"277","author":"Ohl","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbrep.2026.102713_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.17305\/bjbms.2011.2620","article-title":"Serum total antioxidant capacity in patients with multiple sclerosis","volume":"11","author":"Had\u017eovi\u0107-D\u017euvo","year":"2011","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"10.1016\/j.bbrep.2026.102713_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2020.106377","article-title":"Comparison between cerebrospinal fluid and serum levels of myelin-associated glycoprotein, total antioxidant capacity, and 8-hydroxy-2\u2032-deoxyguanosine in patients with multiple sclerosis","volume":"200","author":"Khajenobar","year":"2021","journal-title":"Clin. Neurol. Neurosurg."}],"updated-by":[{"DOI":"10.1016\/j.bbrep.2026.102778","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000}}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826002736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826002736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:05:58Z","timestamp":1791234358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580826002736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":36,"alternative-id":["S2405580826002736"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102713","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of oxidative stress and coagulation factors in MS patients throughout both relapse and remission stages","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102713","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102713"}}